News

Treatment with memantine in a small cohort of individuals with post-traumatic headache led to fewer average headache days per ...
While conventional treatments play a crucial role in mental well-being, a growing body of research and health expert ...
HAMILTON, BM / ACCESS Newswire / July 15, 2025 / Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCQB:CYTOF), a company dedicated to developing therapeutics that address important unmet ...
Medtronic's Jason Fontana offers an update on next-generation Symplicity Spyral devices, procedures and a new feature they're ...
If every pharma company had this, they would have much greater access to their medications without people in the middle." In ...
Of the patients across the two Phase III studies, more than 95% enrolled in the ongoing long-term extension (LTE) study.
Turns out your morning coffee is doing more than you think. Discover how to make it healthier without sacrificing flavor.
Antidepressants can interfere with how the body cools amid hot temperatures meaning some people can be susceptible to heat ...
HAMILTON, BM / ACCESS Newswire / July 15, 2025 / Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCQB:CYTOF), a company dedicated to developing therapeutics that address important unmet med ...
Stopping an SSRI or SNRI isn’t likely to cause ‘clinically significant’ symptoms, a new review suggests, prompting disagreement among experts.
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to TSND-201 (methylone) for the treatment of posttraumatic stress disorder (PTSD).
Cutting a single amino acid from the diet caused rapid, drastic weight loss in mice by converting white fat into ...